A dream deferred

American Journal of Health-System Pharmacy

Volumn 67, Issue 16, 2010, Pages 1319-1325

  Hepler, Charles D ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; COST BENEFIT ANALYSIS; GOAL ATTAINMENT; HUMAN; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; ARTICLE; DRUG USE; HEALTH CARE POLICY; HEALTH CARE QUALITY; MEDICATION THERAPY MANAGEMENT; PATIENT CARE; PROFESSIONAL STANDARD; UNITED STATES;

DRUG UTILIZATION REVIEW; HEALTH CARE REFORM; HUMANS; MEDICATION THERAPY MANAGEMENT; PATIENT-CENTERED CARE; PHARMACISTS; PROFESSIONAL ROLE; QUALITY INDICATORS, HEALTH CARE; UNITED STATES;

EID: 77958016956     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100329     Document Type: Conference Paper

References (27)

1. Zellmer WA. Perspectives on Hilton Head. Am J Health-Syst Pharm. 1986; 43:1439-43. (Pubitemid 16082965)
2. Hughes L. Harlem (2). In: Rampersad A, Roessel D, eds. The collected poems of Langston Hughes. New York: Alfred A. Knopf; 1994:426.
3. Hepler CD. Pharmacy as a clinical profession. Am J Hosp Pharm. 1985; 42:1298-306.
4. Hepler CD, Segal R. Preventing medication errors and improving drug therapy outcomes through system management. Boca Raton, FL: CRC Press; 2003.
5. Perez A, Doloresco F, Hoffman JM et al. ACCP: economic evaluations of clinical pharmacy services: 2001-2005. Pharmacotherapy. 2009; 29:128.
6. Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008; 48:23-31.
7. Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006; 46:133-47. (Pubitemid 46037370)
8. American Society of Health-System Pharmacists. 2015 ASHP Health-System Pharmacy Initiative. www.ashp.org/s-ashp/docs/files/2015-Goals-Objectives-0508. pdf (accessed 2010 Jun 16).
9. American Society of Health-System Pharmacists. Pharmacy Practice Model Initiative. www.ashp.org/Import/PRACTICEANDPOLICY/PPMI.aspx (accessed 2010 Jun 16).
10. Ginsburg DB. The "University of ASHP": Teaching and learning in a new world of practice. Am J Health-Syst Pharm. 2010; 67:1373-6.
11. Rakel RE. Compassion and the art of family medicine: from Osler to Oprah. J Am Board Fam Pract. 2000; 13:440-8. (Pubitemid 33645641)
12. Berwick DM. A user's manual for the IOM's quality chasm report. Health Aff. 2002; 21:80-90.
13. President's Advisory Commission on Consumer Protection and Quality in the Health Care Industry. Quality first: better health care for all Americans. www.hcqualitycommission.gov/prepub/preface.htm (accessed 2010 Jun 15).
14. Institute of Medicine Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001.
15. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47:533-43. (Pubitemid 20138134)
16. Zellmer WA. Unresolved issues in pharmacy. Am J Health-Syst Pharm. 2005; 62:259-65. (Pubitemid 40403540)
17. Abramowitz PW. The evolution and metamorphosis of the pharmacy practice model. Am J Health-Syst Pharm. 2009; 66:1437-46.
18. Breland BD. Believing what we know: pharmacy provides value. Am J Health- Syst Pharm. 2007; 64:1284-91. (Pubitemid 47216197)
19. Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmissions. Med Care. 1991; 29:989-1003.
20. Hohl CM, Zed PJ, Brubacher JR et al. Do emergency physicians attribute drug-related emergency department visits to medication-related problems? Ann Emerg Med. 2009; 55:493-502.
21. National Quality Measures Clearinghouse. Measure index. www.qualitymeasures.ahrq.gov/browse/measureindex.aspx (accessed 2010 Jun 16).
22. MacKinnon NJ, Hepler CD. Indicators of preventable drug-related morbidity in older adults. II. Use in a managed care organization. J Manag Care Pharm. 2003; 9:134-41.
23. MacKinnon NJ, Hepler CD. Preventable drug-related morbidity in older adults. I. Indicator development. J Manag Care Pharm. 2002; 8:365-71.
24. Faris RJ. Explicit definitions to identify preventable drug related morbidity in an elderly population and their use as an indicator of quality in the medication use system. Gainsville, FL: University of Florida; 2001:4448. Dissertation.
25. Sauer BC, Hepler CD, Cherney B et al. Computerized indicators of potential drug-related emergency department and hospital admissions. Am J Manag Care. 2007; 13:29-35. (Pubitemid 46180508)
26. Hepler CD. Four virtues for the future. J Am Pharm Assoc. 1997; NS37:469-73.
27. Famous Poets and Poems. Maya Angelou quotes. http://famouspoetsandpoems. com/poets/maya-angelou/quotes (accessed 2010 Jun 16).